MedPath

Molecular and Microbiota Signatures Underlying Colonic Diverticular Disease

Active, not recruiting
Conditions
Diverticular Disease of Colon
Registration Number
NCT06764550
Lead Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Brief Summary

The pathogenesis of diverticular disease is likely multifactorial in origin. This project aims to study the involvement of environmental factors in the pathophysiology of diverticular disease, the underlying molecular mechanisms, and alterations in the microbiota.

Detailed Description

The pathogenesis of diverticular disease is likely multifactorial in origin. Some studies have demonstrated the role of genetic factors, while others have highlighted the role of environmental factors. The present project aims to study the involvement of environmental factors in the pathophysiology of diverticular disease, the underlying molecular mechanisms, and alterations in the microbiota.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Age between 18 and 75 years.

  • Belonging to one of the following groups:

    1. Patients with diverticula of the colon without symptoms.
    2. Patients symptomatic for diverticular disease.
    3. Subjects undergoing colonoscopy for colorectal cancer prevention or follow-up of previous polypectomies, asymptomatic for digestive symptoms.
  • Obtaining informed consent.

Exclusion Criteria
  • Acute complicated diverticulitis (bleeding, perforation)
  • Previous colon surgery
  • Antibiotics or laxatives within the past 90 days
  • Pregnancy and/or lactation
  • Systemic and psychiatric disorders
  • Asthma, food allergies and other allergic-type disorders
  • Possible diseases leading to intestinal bacterial contamination (diabetes, blind loop syndrome, rheumatologic diseases).

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assess the interaction between host factors and gut microbiota3 years

Assess the interaction between host factors and gut microbiota

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

IRCCS Azienda Ospedaliero-Universitaria di Bologna

🇮🇹

Bologna, Italy

© Copyright 2025. All Rights Reserved by MedPath